With deep understanding of imaging evaluation criteria, FAB provides all-round support to launch new drugs by means of involving in a number of projects to speed up the completion of evaluation process, to shorten the time of clinical trials, to support CDE meetings, to do research and collect data relying on excellent expert team, experience about excellent projects and operational management skills, and high-efficient execution.
47 projects have been submitted to NMPA, and 27 projects have been successfully approved for marketing, such as Pyrotinib Maleate Tablets, Pralatrexate, Almonertinib Mesilate Tablets, etc.
Self-developed innovative drug for the treatment of breast cancer
For the treatment of relapsed or refractory peripheral T cell lymphoma (PTCL)
A class 1 innovative drug self-developed by Hansoh Pharmaceutical
A class 1 innovative drug self-developed by Zelgen Biopharmaceuticals
A class 1 innovative drug self-developed by Allist Pharmaceuticals
A class 1 innovative drug self-developed by Hengrui Pharmaceuticals
A class 1 innovative drug self-developed by Hengrui Pharmaceuticals
Original Chinese medicine icariin soft capsule developed by shengnuoji
A class 1 innovative drug self-developed by Haihe Pharmaceuticals
A category-I innovative drug self-developed by Dizal Pharmaceutical
Recombinant Human-Mouse anti-CD20 monoclonal antibody jointly developed by Lilly and Innovent
The world's first subcutaneous PD-L1 inhibitor
Lilly and Innovent jointly developed an innovative PD-1 inhibitor Sintilimab
Novel anti-CD20 monoclonal antibody self-developed by Sinocelltech
PD-1 (programmed death receptor 1) monoclonal antibody independently developed by Henlius
BioRay developed a human-mouse chimeric monoclonal antibody targeting the CD20 antigen on the surface of B cells
Innovent and IASO Bio jointly developed an innovative fully-human anti- BCMA CAR-T cell therapy
Shanghai Office
Rm 208, Building 1, Universal Science & Technology Plaza, No. 958 Zhenbei Rd, Shanghai, China
Hanzhou Office
Rm 1802, Fl.18, Building 8, No. 19, Jugong Rd, Xixing Street, Binjiang District, Hangzhou, China
Jiaxing Office
Rm 416, Tigermed Building, No. 28 Huixin Rd, Daqiao Town, Nanhu District, Jiaxing, China
Follow Us
Home
Services
Telephone
Message